{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:13:34Z","timestamp":1760242414809},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1378\/chest.08-2482","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T02:58:27Z","timestamp":1237949907000},"page":"220-228","source":"Crossref","is-referenced-by-count":22,"title":["Apoptosis-Related (Survivin, Bcl-2), Tumor Suppressor Gene (p53), Proliferation (Ki-67), and Non-Receptor Tyrosine Kinase (Src) Markers Expression and Correlation With Clinicopathologic Variables in 60 Thymic Neoplasms"],"prefix":"10.1016","volume":"136","author":[{"given":"Thaer","family":"Khoury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaozeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rameela","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadir","family":"Alrawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-2482_bib1","series-title":"Tumors of the mediastinum: atlas of tumor pathology. Third series, Fascicle 21","first-page":"40","article-title":"Epithelial tumors thymoma","author":"Shimosato","year":"1997"},{"key":"10.1378\/chest.08-2482_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/106689690401200412","article-title":"Ki-67 antigen expression predicts survival and correlates with histologic subtype in WHO classification of thymic epithelial tumors","volume":"12","author":"Comin","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1378\/chest.08-2482_bib3","series-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart: World Health Organization classification of tumors","first-page":"146","article-title":"Tumors of the thymus","author":"Muller-Hermelink","year":"2004"},{"key":"10.1378\/chest.08-2482_bib4","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1055\/s-2007-985647","article-title":"Thymoma: incidence, classification and therapy","volume":"132","author":"Stremmel","year":"2007","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1378\/chest.08-2482_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymic cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1378\/chest.08-2482_bib6","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1186\/1746-1596-2-13","article-title":"Thymomas: a cytologic and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers","volume":"2","author":"Alexiev","year":"2007","journal-title":"Diagn Pathol"},{"key":"10.1378\/chest.08-2482_bib7","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/01.MP.0000038463.67854.84","article-title":"Proliferative activity and apoptosis in thymic epithelial neoplasm","volume":"15","author":"Hiroshima","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1378\/chest.08-2482_bib8","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.21433","article-title":"Long term disease-free survival of patients with radically resected thymomas","volume":"104","author":"Mineo","year":"2005","journal-title":"Cancer"},{"key":"10.1378\/chest.08-2482_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<180::AID-IJC5>3.0.CO;2-W","article-title":"p53 expression and proliferative activity predicts survival in non-invasive thymomas","volume":"69","author":"Pich","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1378\/chest.08-2482_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00432-005-0682-z","article-title":"Cellular localization of survivin: impact on the prognosis of colorectal cancer","volume":"131","author":"Ponelle","year":"2005","journal-title":"J Cancer Research Clin Oncol"},{"key":"10.1378\/chest.08-2482_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1378\/chest.08-2482_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases","volume":"13","author":"Thomas","year":"1997","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1378\/chest.08-2482_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00280-008-0699-5","article-title":"Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor","volume":"62","author":"Luo","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1378\/chest.08-2482_bib14","first-page":"114","article-title":"Src in cancer: deregulation and consequences for cell behavior","volume":"1602","author":"Frame","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1378\/chest.08-2482_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/378509a0","article-title":"Myc but not Fos rescue of PDGF signaling block caused by kinase-inactive Src","volume":"378","author":"Barone","year":"1995","journal-title":"Nature"},{"key":"10.1378\/chest.08-2482_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/5971","article-title":"Activating SRC mutation in a subset of advanced human colon cancers","volume":"21","author":"Irby","year":"1999","journal-title":"Nat Genet"},{"key":"10.1378\/chest.08-2482_bib17","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stage","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1378\/chest.08-2482_bib18","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/00000478-199612000-00006","article-title":"Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma: a clinicopathologic study of 22 cases","volume":"20","author":"Suster","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1378\/chest.08-2482_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2007.11.011","article-title":"The role of survivin on overall survival of non-small cell lung cancer, meta-analysis of published literatures","volume":"61","author":"Fan","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1378\/chest.08-2482_bib20","first-page":"139","article-title":"SRC in human carcinogenesis","volume":"1","author":"Russello","year":"2004","journal-title":"Front Biosci"},{"key":"10.1378\/chest.08-2482_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","article-title":"Expression of apoptosis related markers and HER-2\/neu in thymic epithelial tumors","volume":"43","author":"Pan","year":"2003","journal-title":"Histopathology"},{"key":"10.1378\/chest.08-2482_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1023772912750","article-title":"Src family kinases in tumor progression and metastasis","volume":"22","author":"Summy","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1378\/chest.08-2482_bib23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1517\/14728222.11.9.1207","article-title":"Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors","volume":"11","author":"Park","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"10.1378\/chest.08-2482_bib24","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1158\/0008-5472.CAN-07-2997","article-title":"Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model","volume":"68","author":"Park","year":"2008","journal-title":"Cancer Res"},{"key":"10.1378\/chest.08-2482_bib25","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1038\/sj.onc.1208079","article-title":"The interplay between Src family kinases and receptor tyrosine kinases","volume":"23","author":"Bromann","year":"2004","journal-title":"Oncogene"},{"key":"10.1378\/chest.08-2482_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2559.1997.5730805.x","article-title":"Expression of p53, mdm2, p21\/waf1 and Bcl-2 proteins in thymomas","volume":"30","author":"Stefanaki","year":"1997","journal-title":"Histopathology"},{"key":"10.1378\/chest.08-2482_bib27","first-page":"339","article-title":"Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)","volume":"90","author":"Fukiwake","year":"1999","journal-title":"Fukuoka Igaku Zasshi"},{"key":"10.1378\/chest.08-2482_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/bjc.1997.561","article-title":"High frequency of p53 protein expression in thymic carcinoma but not in thymoma","volume":"76","author":"Hino","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1378\/chest.08-2482_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ceb.2006.08.015","article-title":"The case of survivin as a regulator of microtubule dynamics and cell-death decisions","volume":"18","author":"Altieri","year":"2006","journal-title":"Cur Opin Cell Biol"},{"key":"10.1378\/chest.08-2482_bib30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ceb.2006.08.016","article-title":"The case of survivin as mitotic regulator","volume":"18","author":"Lens","year":"2006","journal-title":"Cur Opin Cell Biol"},{"key":"10.1378\/chest.08-2482_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1172\/JCI200422222","article-title":"Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis","volume":"114","author":"Dohi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.08-2482_bib32","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","article-title":"Survivin, versatile modulation of cell division and apoptosis in cancer","volume":"22","author":"Altieri","year":"2002","journal-title":"Oncogene"},{"key":"10.1378\/chest.08-2482_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ijc.20768","article-title":"Nuclear or cytoplasmic expression of survivin: what is the significance?","volume":"114","author":"Fengzhi","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1378\/chest.08-2482_bib34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1535-7163.MCT-05-0375","article-title":"Survivin, a cancer target with an emerging role in normal adult tissues","volume":"5","author":"Fukuda","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1378\/chest.08-2482_bib35","first-page":"1098","article-title":"Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival","volume":"9","author":"Kappler","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1378\/chest.08-2482_bib36","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E","article-title":"Expression of survivin correlates with apoptosis proliferation and angiogenesis during human colorectal tumorigenesis","volume":"91","author":"Kawasaki","year":"2001","journal-title":"Cancer"},{"key":"10.1378\/chest.08-2482_bib37","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/sj.bjc.6602632","article-title":"Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients","volume":"92","author":"Tonini","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1378\/chest.08-2482_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.bjc.6602904","article-title":"Expression of cytoplasmic and nuclear survivin in primary and secondary glioblastoma","volume":"94","author":"Xie","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1378\/chest.08-2482_bib39","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/jbc.M106643200","article-title":"Transcriptional repression of the anti-apoptotic survivin gene by the wild type p53","volume":"277","author":"Hoffman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1378\/chest.08-2482_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.20032092","article-title":"Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death","volume":"199","author":"Okada","year":"2004","journal-title":"J Exp Med"},{"key":"10.1378\/chest.08-2482_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1582-4934.2005.tb00361.x","article-title":"Survivin as a target for new anticancer interventions","volume":"9","author":"Zaffaroni","year":"2005","journal-title":"J Cell Mol Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369209604268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369209604268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T22:30:08Z","timestamp":1545345008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369209604268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0012369209604268"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-2482","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}